HbA1c as an Early Serologic Marker for the Hemodynamic Progression of Stage A Heart Failure

Status unconfirmed

Conditions studied: Heart Failure, Diastolic

In brief

In a retrospective community based cohort study from Pueblo County Colorado which has a higher population proportion of metabolic syndrome and diabetes mellitus, we hope to clarify and quantify an association of the AGE HBa1c elevation with the early subclinical hemodynamic changes of diabetic cardiomyopathy as measured by LAV, LVM, E/A ratio, E/e' ratio and BNP in patients with stage A heart failure.

Key facts

Study ID

NCT04450576

Run by

Parkview Medical Center

People needed

200

Starts

2019-12-20

Expected to finish

2020-12-30

Last updated by the study team

2020-11-16

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Stage A heart failure on basis of metabolic criteria

You may not qualify if…

• LV dysfunction, valvular heart disease, hypertension and CAD

Where it is running

• Parkview Medical Center — Pueblo, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.